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Glycosomal (microbody)-enriched fractions prepared from epimastigote Trypanosoma cruzi were used as 
a partially purified source of phosphofructokinase. D-Fructose 6-phosphate showed sigmoidal kinetics at 
pH 7.0, but hyperbolic kinetics at pH 8.0. Various adenosine nucleotides were positive effecters; S-AMP 
was the most powerful. ATP showed hyperbolic kinetics under all conditions tested. Several described in- 
hibitors and activators of mammalian phosphofructokinase were without significant effect on the trypanoso- 
ma1 enzyme; the absence of effect of D-fructose 2,6_bisphosphate is of particular note. 
Phosphofructokinase D-Fructose 2,6-bisphosphate (Trypanosoma cruzi, Parasitic protozoon) 
1. INTRODUCTION 
Chagas’ disease is a major cause of suffering 
and death in Latin America. The aetiological agent 
is the parasitic protozoon, Trypanosoma cruzi. 
There is no effective chemotherapy for established 
cases [I]. Recognition of differences in host and 
parasite biochemistry may help change this fact. 
The early glycolytic enzymes in the related T. 
brucei are contained in a microbody-like organelle, 
the glycosome [2]. Phosphofructokinase (ATP : D- 
fructosed-phosphate 1-phosphotransferase, EC 
2.7.1.11; PFK) is particulate and shows detergent 
latency in all three developmental stages of T. cruzi 
[3]. A glycosomal location has now been estab- 
lished [4]. 
PFK is a key regulatory enzyme of glycolysis in 
mammalian cells [5], and recently D-fructose 
2,6-bisphosphate (F26Pz) has been described as a 
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powerful positive effector of PFK from many 
sources [6]. PFK shows a broadly similar pattern 
of regulation in several other members of the order 
Kinetoplastida related to T. crud; D-fructose 
6-phosphate (F6P) kinetics are sigmoidal, 5 ’ -AMP 
is a positive effector, but no other important effec- 
tors have been identified. F26Pz is without effect 
on the enzyme from T. brucei [7]. PFK studied in 
T. cruzi, however, failed to show sigmoidal 
kinetics with F6P; the effect of F26P2 was not ex- 
amined [8]. 
In this paper, glycosomal fractions prepared 
from epimastigote T. cruzi cultures were used as a 
source of partially purified PFK. Sigmoidal 
kinetics were demonstrated with F6P as substrate 
under some assay conditions and no stimulation by 
F26P2 was detected. 
2. MATERIALS AND METHODS 
Media components were obtained from Difco. 
Biochemicals and enzymes were obtained from 
Boehringer or Sigma. Chemicals were supplied by 
BDH or Fisons. 
The Sonya strain of T. cruzi [9] was maintained 
in liquid medium [lo] by serial passage. Mid-log 
262 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 
Volume 201, number 2 FEBS LETTERS June 1986 
cultures were harvested by centrifugation and 
washed once in buffered saline then once in 
breakage medium (0.25 M sucrose, 1mM 
disodium edetate, 25 mM Tris-HCl, pH 7.6). After 
resuspension in breakage medium, cells were 
broken by grinding with silicon carbide [ 111. After 
a low-speed centrifugation to remove abrasive, a 
5000 x g (10 min) supernatant was prepared and 
applied to the top of a linear 0.8-2.0 M sucrose 
gradient; volume 20 ml. After centrifugation at 
130000 x g for 180 min the gradient was frac- 
tionated and glycosomal fractions with an average 
density of 1.23 g/ml were pooled and stored in 
liquid nitrogen until assayed. Preparative cen- 
trifugations were performed using an MSE 
Prepspin 50 ultracentrifuge. 
Two PFK assays were employed: (a) contained 
66 mM Hepes (pH in text), 5 mM MgS04, 1 mM 
disodium edetate, 0.2 mM NADH, 3 U/ml 
aldolase, 4.5 U/ml triosephosphate isomerase, 
4.5 U/ml glycerol-3-phosphate dehydrogenase, 
*r 
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Fig. I. The effects of varying pH and of the addition of 
5 ‘-AMP on F6P kinetics. All assays contained fixed 
[ATP] = 0.5 mM; all other assay conditions were those 
given in section 2. n , pH 8.0; l , pH 7.0; A , pH 7.0, 
3 mM AMP; 0, pH 7.0, 30rM AMP. 
Table 1 
Effector screen 
No effect 
2-Phosphoglycerate 
2,3-Diphosphoglycerate 
Phosphoenolpyruvate 
6-Phosphogluconate 
Calcium chloride 
Potassium chloride 
Ammonium acetate 
Inosine 5 ’ -diphosphate 
Inorganic phosphate 
Aspartic acid 
Glutathione (oxidised and 
reduced forms) 
Citrate 
Isocitrate 
Succinate 
D-Fructose 1,dbisphosphate 
Oleate (50 /cM) 
Stimulatory effect 
5 ’ -AMP 
3 ’ -AMP 
cyclic AMP 
ADP 
3-phosphoglycerate 
Inhibitory effect 
calcium chloride (5 mM) 
D-glucose 1 ,dbisphosphate 
D-fructose 2,6-bisphosphate 
oleate (0.25 mM) 
Working at Fixed assay conditions, at pH 7.5, PFK activity in the presence or absence of various 
possible effecters was measured. Each rate was performed in triplicate then the mean values 
compared. Stimulatory and inhibitory effecters were defined as those causing greater than 25% 
change in reaction rate. Each putative effector was added to a final concentration of 1 mM unless 
otherwise specified 
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0.1% (w/v) Triton X-100, and ATP and F6P to 
final concentrations as specified; (b) contained 
66 mM Hepes (pH in text), 5 mM MgS04, 10 mM 
KCI, 1 mM disodium edetate, 0.2 mM NADH, 
0.71 mM phosphoenolpyruvate, 7 U/ml pyruvate 
kinase, 10 U/ml lactate dehydrogenase, 0.1% 
(w/v) Triton X-100, and ATP and F6P to final 
concentrations as specified. 
In both assays, water and glycosomal extract 
were added to a final volume of 1.0 ml. Assay (b) 
was only used when D-fructose 1,6-bisphosphate 
was added. All coupling enzymes had been exten- 
sively dialysed to remove ammonium sulphate. As 
the glycosomal extracts contained contaminating 
phosphoglucose isomerase activity, all assays con- 
tained both F6P and D-glucose 6-phosphate in 
molar ratio 1 : 2.5 [12]. Reaction rates were 
measured by recording the decrease in &III caused 
by the coupled oxidation of NADH. Assays were 
performed on a Unicam SP8000 double beam 
recording spectrophotometer with the cuvette 
holder maintained at 28°C. 
3. RESULTS 
The effect of pH on F6P kinetics is shown in 
fig. 1. Sigmoidal kinetics were obtained at pH 7.0, 
whilst they were hyperbolic at pH 8.0. Hill plots 
(not shown) gave Hill coefficients of 1.9 at the 
lower pH, and 0.84 at the higher value. 
The results of a screen for possible effecters are 
shown in table 1. Of the glycolytic and tricarbox- 
ylic acid cycle intermediates examined, only 
3-phosphoglycerate appreciably changed the reac- 
tion rate (it was weakly stimulatory). All the 
adenosine nucleotides examined were strongly 
stimulatory. Various other described positive ef- 
fectors of PFK from other sources were either 
without effect or were inhibitory. 
Fig. 1 also shows that the addition of 5 ‘-AMP 
caused F6P kinetics at pH 7.0 to become hyper- 
bolic, with an increase in affinity of PFK for F6P. 
The K,,, for F6P at pH 8.0 is 1.9 mM; at pH 7.0 in 
the presence of 3 mM 5 ‘-AMP it is 50 PM; the 
K mapp at pH 7.0 in the absence of 5 ‘-AMP is 
5.8 mM. 
ATP kinetics at fixed [F6P] were hyperbolic at 
both pH 7.0 and pH 8.0; Hill coefficients were less 
than unity. No marked inhibition was seen at con- 
centrations of ATP up to 5 mM. The addition of 
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5 ‘-AMP (0.1 mM) caused the K,,, of ATP to fall 
from 1.75 mM to 0.80 mM at pH 7.0; at pH 8.0, 
Km = 0.40 mM (not shown). 
The relative Kmapp values of various adenosine 
phosphate stimulators of PFK are shown in table 
2. 5’-AMP is the most potent stimulator of activi- 
ty, cyclic AMP (adenosine 3 ’ ,5 ’ -cyclic 
monophosphate) the least. The effect of adding D- 
fructose 2,6-bisphosphate on F6P kinetics is shown 
in fig.2. Some inhibition is visible at F26Pz = 
Table 2 
Effectiveness of different adenosine nucleotides as 
stimulators of PFK 
Adenosine nucleotide K maw 
Cyclic AMP 
ADP 
3 ’ -AMP 
5 ’ -AMP 
2.6 mMa 
0.28 mM 
0.77 mM 
33 /M 
a Determined at pH 7.0; other nucleotide Kmapp values 
were determined at pH 8.0 
Low [F6P] and [ATP] were chosen such that PFK 
activity was negligible. The addition of different 
concentrations of each effector caused a hyperbolic 
stimulation of activity in each case, from which Kmapp 
values were calculated using double reciprocal plots (not 
shown) 
6 
0 
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Fig.2. The effect of adding F26P2 on F6P kinetics. Each 
assay contained fixed [ATP] = 0.5 mM, and was 
performed at pH 7.0. Other assay conditions were as 
given in section 2. l , no F26P2 added; 0, 0.1 mM 
F26Pz; A , 0.5 mM F26Pz. 
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0.1 mM; it is more marked at 0.5 mM. These data 
support the result for F26Pz shown in table 1. The 
F26Pz used stimulated a commercially obtained 
rabbit muscle PFK; mixing experiments failed to 
demonstrate any inhibitor of this action in the 
glycosomal preparation used (not shown). 
4. DISCUSSION 
PFK examined in a partially purified glycosomal 
fraction from epimastigote T. cruzi showed 
cooperativity of binding of F6P at low pH, but no 
evidence of ATP cooperative binding, nor was 
there any significant inhibition by high [ATP] (up 
to 5 mM). Adenosine nucleotides were stimulators 
of PFK activity, 5 ‘-AMP being the most potent. 
Various other effecters of mammalian PFK did 
not act similarly on the T. cruzi enzyme. In par- 
ticular, the sugar bisphosphates including F26P2 
had no stimulatory effect; the inhibition seen with 
F26P2 was probably non-allosteric in nature. Rais- 
ing the pH increased the affinity of PFK for both 
substrates. 
This pattern of regulation resembles that seen 
for PFK in other members of order the 
Kinetoplastida including Leishmania donovani 
and L. braziliensis [ 131, Crithidia fasciculata [ 141, 
and T. brucei [7,15]. Lowering the pH inhibits 
PFK from T. cruzi, which is also seen in mam- 
malian PFK [5] and that in C. fasciculata [14], 
although the opposite is observed in L. donovani 
[ 131. PFK purified from epimastigote T. cruzi by 
sonication followed by ammonium sulphate 
precipitation showed no cooperativity of F6P 
binding [8] at pH 7.4; possible explanations in- 
clude the method of purification, or contamina- 
tion of ATP by 5’-AMP. It is also of note that 
PFK purified from T. brucei by a method similar 
to that employed in this paper showed a Kmapp for 
5 ‘-AMP of 7 yM [15], whilst PFK purified to 
homogeneity from the same organism [7] had a 
K mapp for 5’-AMP at 0.64 mM. The glycolytic 
glycosomal enzymes of T. brucei are very tightly 
associated [161, and over-purification may alter the 
kinetic properties of PFK, a phenomenon noted 
when the enzyme is obtained from various other 
sources [ 171. Glycosomal fractions in T. cruzi con- 
tain low hydrolase activities [4] and the in- 
terference caused by copurified phosphoglucose 
isomerase was eliminated (v.s.). 
Mammalian PFK is modulated in a highly com- 
plex fashion, and possesses at least nine different 
regulatory sites [ 181. The isofunctional enzyme in 
T. cruzi has a far simpler pattern of regulation 
resembling related members of the order 
Kinetoplastida previously examined. The lack of 
stimulatory effects of F26P2 shown here agrees 
with a similar lack of effect on the purified enzyme 
from T. brucei [7]. F26P2 is the most potent 
positive effector known for PFK from most 
eukaryotic sources [6]; perhaps the glycosomal 
localisation of the enzyme in members of the order 
Kinetoplastida reflects an early evolutionary 
divergence of modes of control of PFK in this 
order. A proton gradient across the glycosomal 
membrane could regulate PFK; such a gradient is 
maintained in vacuoles in Saccharomyces 
carlsbergensis by an ATP-dependent membrane 
proton pump [23]. 
The high value for Kmapp for CAMP suggests 
that this compound is not a physiological effector 
of PFK in T. cruzi; it is of note that CAMP- 
receptor proteins in T. cruzi [20] and T. brucei [21] 
are predominantly cytosolic, and that adenyl 
cyclase is associated with the plasma membrane of 
T. cruzi [22]. 
Inhibition of PFK by oleate occurs at 0.25 mM 
but not at 50pM. The former concentration of 
free fatty acid is probably grossly unphysiological, 
and PFK is unlikely to be modulated in T. cruzi by 
this compound; it is of relevance that ,&-oxidation 
in this organism appears to have no glycosomal 
component [4]. 
Glucose is the most important exogenous energy 
substrate for the trypomastigote (bloodstream) 
form of T. cruzi, and the same is probably true of 
the amastigote (intracellular, tissue) stage [19]. All 
three morphological forms possess particulate 
PFK, presumably glycosomal [3]. The pattern of 
regulation of PFK in the easily obtained culture 
epimastigote is probably mirrored in the other two 
stages described above, which parasitise man. An- 
tileishmanial antimonial drugs probably act by in- 
hibiting PFK [19], and it is to be hoped that the 
trypanosomal enzyme here described may also be 
selectively inhibited by a new drug some day. 
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